Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 18, 2025Biological Sciences

Advancements in Microbial Drug Discovery: Leveraging AI, CRISPR, and Microbiome Insights to Overcome Antimicrobial Resistance

View Full Paper
Ask AI
Bookmark
Share

Authors

IAIbrahim AbdulrazaqSEShehu-Alimi EleluGIGaniyat Omotayo Ibrahim

Discussion

Loading...

Member takes

Overview

This study explores AI and CRISPR for overcoming antimicrobial resistance, suggesting innovative pathways for drug discovery.

Key Points

  • The integration of AI-driven platforms significantly enhances the speed and effectiveness of drug discovery.
  • CRISPR technology provides targeted solutions to combat antimicrobial resistance at the genetic level.
  • Microbiome insights offer a potential framework to restore balance and enhance immune function.
  • Despite advances, challenges in data quality and clinical translation continue to hinder progress.

Cite This Study

Abdulrazaq et al. (2025) studied this question.

synapsesocial.com/papers/68d434ea713b0b5dfea7480fhttps://doi.org/10.55006/biolsciences.2025.5304
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A Decade Of AI-Accelerated Drug Discovery Against Antimicrobial Resistance (2015–2025): Insights And Future Directions2025 · 2 citations
  2. 2Advances in Antimicrobial Resistance (AMR) — Novel Therapeutic Strategies and Diagnostics2025
  3. 3Harnessing AI-Driven CRISPR Bioinformatics: Transforming precision diagnostics for antimicrobial resistance and chemical pathology2025
  4. 4Biotechnological Innovations to Combat Antimicrobial Resistance and Advance Global Health Equity2025
  5. 5AI-Driven Strategies to Forecast and Combat Antibiotic Resistance2025